2nd TGFB for Immuno-Oncology Drug Development

Paid

The Leading TGF-ß for Immuno-Oncology Summit Returns Exclusively Dedicated to Exploring the Role of TGF-ß in Cancer Therapeutics It is evident that TGF-ß holds exciting therapeutic promise to IO drug developers but with the complexity of this target, there are still many hurdles to overcome.

25-27 January 2022

Healthcare

10th Tumor Models For Combination Targeted Oncology Summit

Paid

From Leveraging Emerging Predictive Technologies to Engineering a Human-Physiologically Relevant Models – Deepen Our Understanding of Tumor Biology, Resistance Mechanisms & Dosing Strategy Following the success of KRAS, HER2, BCMA, drug developers have seen a new wave of novel, combination targeted oncology surging through pipeline.

12-14 July 2022

Healthcare

4th Inflammasome Therapeutics Summit

Paid

Welcome to the 4th Inflammasome Therapeutics Summit The Only Meeting Uniting Industry & Academia to Progress Inflammasome-Centered Drug Development The 4th Inflammasome Therapeutics Summit returns to Boston, uniting industry pioneers during this exciting new era in inflammasome therapeutic research.

29 November-01 December 2022

Healthcare